1. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
    Valentina Schiavoni et al, 2023, Cancers CrossRef
  2. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
    Peizhi Zhang et al, 2023, Frontiers in Oncology CrossRef
  3. Multi-Organ Nutrigenomic Effects of Dietary Grapes in a Mouse Model
    Asim Dave et al, 2023, Antioxidants CrossRef
  4. Explore Key Genes and Mechanisms Involved in Colon Cancer Progression Based on Bioinformatics Analysis
    Yongting Lan et al, 2024, Applied Biochemistry and Biotechnology CrossRef
  5. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
    Yunfei Wang et al, 2023, BMC Cancer CrossRef
  6. GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
    Weidan Zhang et al, 2024, International Journal of Oncology CrossRef
  7. TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression
    Lingling Xie et al, 2023, PeerJ CrossRef
  8. Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma
    Nikolas Dovrolis et al, 2023, Cancers CrossRef